Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 2
1949 7
1950 3
1951 3
1952 2
1953 4
1954 1
1955 1
1956 2
1958 1
1959 2
1960 4
1961 8
1962 9
1963 7
1964 3
1965 2
1967 2
1968 1
1969 2
1970 1
1971 3
1972 2
1973 1
1979 1
1983 2
1984 1
1985 2
1986 2
1987 2
1988 2
1989 3
1990 3
1991 7
1992 7
1993 3
1994 5
1995 8
1996 6
1998 1
2000 3
2002 1
2006 2
2007 1
2008 2
2009 3
2010 5
2011 2
2012 3
2013 2
2014 4
2015 8
2016 6
2017 2
2018 7
2019 10
2020 7
2021 4
2022 7
2023 11
2024 11
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
Liberation from Respiratory Support in Bronchopulmonary Dysplasia.
Kielt MJ, Zaniletti I, Lagatta JM, Padula MA, Grover TR, Porta NFM, Wymore EM, Jensen EA, Leeman KT, Levin JC, Evans JR, Yallapragada S, Nelin LD, Vyas-Read S, Murthy K; Children's Hospitals Neonatal Consortium Severe BPD Focus Group. Kielt MJ, et al. J Pediatr. 2025 Jul;282:114390. doi: 10.1016/j.jpeds.2024.114390. Epub 2024 Nov 8. J Pediatr. 2025. PMID: 39521174
Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa.
Jover I, Ramos MC, Escámez MJ, Lozoya E, Tormo JR, de Prado-Verdún D, Mencía Á, Pont M, Puig C, Larraufie MH, Gutiérrez-Caballero C, Reyes F, Trincado JL, García-González V, Cerrato R, Andrés M, Crespo M, Vicente F, Godessart N, Genilloud O, Larcher F, Nueda A. Jover I, et al. Among authors: pont m. Sci Rep. 2024 Aug 16;14(1):18969. doi: 10.1038/s41598-024-67398-8. Sci Rep. 2024. PMID: 39152155 Free PMC article.
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN 3rd, Coffey DG, Tuazon SA, Wood B, Gooley T, Wu VQ, Voutsinas J, Song X, Shadman M, Gauthier J, Chapuis AG, Milano F, Maloney DG, Riddell SR, Green DJ. Cowan AJ, et al. Among authors: pont mj. Lancet Oncol. 2023 Jul;24(7):811-822. doi: 10.1016/S1470-2045(23)00246-2. Lancet Oncol. 2023. PMID: 37414012 Free PMC article. Clinical Trial.
[Orthostatic hypotension].
HERMANN H, PONT M. HERMANN H, et al. Among authors: pont m. Presse Med (1893). 1946 Apr 27;54:269. Presse Med (1893). 1946. PMID: 20982454 French. No abstract available.
A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up.
Tuazon SA, Portuguese AJ, Pont MJ, Cowan AJ, Cole GO, Sather BD, Song X, Thomas S, Wood BL, Blake M, Works MG, Shadman M, Liang EC, Wu QV, Voutsinas JM, Gooley TA, Turtle CJ, Till BG, Coffey DG, Maloney DG, Riddell SR, Green DJ. Tuazon SA, et al. Among authors: pont mj. Blood. 2025 Jul 31;146(5):535-545. doi: 10.1182/blood.2024027681. Blood. 2025. PMID: 40198877 Clinical Trial.
227 results